Dow Up0.64% Nasdaq Up0.68%

More On 009420.KS

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


HanAll Biopharma Co., Ltd. (009420.KS)

-KSE
4,145.00 Up 35.00(0.85%) 9:22PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Assets
Current Assets
Cash And Cash Equivalents11,134,000  17,145,000  15,634,000   -  
Short Term Investments6,855,000  23,950,000  8,360,000   -  
Net Receivables23,365,000  25,349,000  29,240,000   -  
Inventory18,103,000  17,124,000  14,601,000   -  
Other Current Assets1,649,000  1,816,000  2,186,000   -  
Total Current Assets 61,314,000   85,521,000   70,195,000   -  
Long Term Investments805,000  1,286,000  1,293,000   -  
Property Plant and Equipment -   -   -   -  
Goodwill -   -   -   -  
Intangible Assets -   -   -   -  
Accumulated Amortization -   -   -   -  
Other Assets -   -   -   -  
Deferred Long Term Asset Charges1,474,000  2,187,000  1,157,000   -  
Total Assets 97,852,000   124,275,000   105,456,000   -  
Liabilities
Current Liabilities
Accounts Payable3,206,000  5,141,000  3,900,000   -  
Short/Current Long Term Debt17,280,000  26,672,000  35,796,000  52,460,000  
Other Current Liabilities9,589,000  7,096,000  9,393,000   -  
Total Current Liabilities 32,946,000   41,482,000   44,801,000   -  
Long Term Debt -   -  6,795,000   -  
Other Liabilities -   -   -   -  
Deferred Long Term Liability Charges17,136,000  20,911,000  17,849,000   -  
Minority Interest -   -   -   -  
Negative Goodwill -   -   -   -  
Total Liabilities 38,225,000   45,604,000   54,755,000   -  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -   -  
Redeemable Preferred Stock -   -   -   -  
Preferred Stock -   -   -   -  
Common Stock72,055,000  67,045,000  36,983,000   -  
Retained Earnings(10,009,000)11,361,000  13,874,000   -  
Treasury Stock(2,419,000)265,000  (156,000) -  
Capital Surplus -   -   -   -  
Other Stockholder Equity -   -   -   -  
Total Stockholder Equity -   -   -   -  
Net Tangible Assets -   -   -   -  

Currency in KRW.